PDE4C
Basic information
Region (hg38): 19:18207965-18248200
Previous symbols: [ "DPDE1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PDE4C gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 44 | 48 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 44 | 4 | 2 |
Variants in PDE4C
This is a list of pathogenic ClinVar variants found in the PDE4C region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-18210947-G-A | Likely benign (Aug 01, 2022) | |||
19-18210994-C-G | not specified | Uncertain significance (Jul 14, 2021) | ||
19-18210996-G-C | not specified | Uncertain significance (Jun 16, 2023) | ||
19-18211054-C-T | not specified | Uncertain significance (Feb 13, 2025) | ||
19-18211090-G-T | not specified | Uncertain significance (Jan 31, 2024) | ||
19-18211108-C-G | not specified | Uncertain significance (Feb 22, 2025) | ||
19-18211120-G-A | not specified | Likely benign (Nov 21, 2023) | ||
19-18211153-G-T | not specified | Uncertain significance (Jul 14, 2021) | ||
19-18211164-T-C | not specified | Uncertain significance (May 27, 2022) | ||
19-18211254-G-A | not specified | Uncertain significance (Mar 18, 2024) | ||
19-18211266-A-G | not specified | Uncertain significance (Mar 01, 2024) | ||
19-18211267-T-C | not specified | Uncertain significance (Nov 30, 2022) | ||
19-18211761-G-C | not specified | Uncertain significance (Mar 05, 2025) | ||
19-18211814-C-A | not specified | Uncertain significance (Sep 13, 2023) | ||
19-18211877-C-T | not specified | Uncertain significance (Apr 05, 2023) | ||
19-18211880-T-C | not specified | Uncertain significance (Jan 18, 2025) | ||
19-18213406-C-T | not specified | Uncertain significance (Jul 26, 2021) | ||
19-18216749-T-C | not specified | Uncertain significance (Jul 02, 2024) | ||
19-18216803-C-T | not specified | Uncertain significance (May 09, 2024) | ||
19-18216838-G-A | not specified | Uncertain significance (Jan 23, 2024) | ||
19-18216849-G-T | not specified | Uncertain significance (Sep 06, 2022) | ||
19-18216877-A-G | not specified | Uncertain significance (Feb 09, 2023) | ||
19-18216878-T-C | not specified | Uncertain significance (Sep 25, 2023) | ||
19-18218153-G-C | not specified | Uncertain significance (Jul 26, 2021) | ||
19-18218217-G-A | not specified | Uncertain significance (Nov 21, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PDE4C | protein_coding | protein_coding | ENST00000355502 | 15 | 47459 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.48e-7 | 0.991 | 125685 | 1 | 62 | 125748 | 0.000251 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.41 | 344 | 426 | 0.807 | 0.0000256 | 4609 |
Missense in Polyphen | 123 | 152.57 | 0.80617 | 1642 | ||
Synonymous | 1.25 | 168 | 190 | 0.885 | 0.0000125 | 1451 |
Loss of Function | 2.38 | 16 | 30.1 | 0.532 | 0.00000145 | 333 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000848 | 0.000814 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000292 | 0.000290 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000387 | 0.000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes. {ECO:0000269|PubMed:17727341}.;
- Pathway
- cAMP signaling pathway - Homo sapiens (human);Purine metabolism - Homo sapiens (human);Morphine addiction - Homo sapiens (human);Beta-agonist/Beta-blocker Pathway, Pharmacodynamics;G Protein Signaling Pathways;Phosphodiesterases in neuronal function;Signaling by GPCR;Signal Transduction;G alpha (s) signalling events;DARPP-32 events;Purine nucleotides nucleosides metabolism;Opioid Signalling;G alpha (i) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.174
Intolerance Scores
- loftool
- 0.417
- rvis_EVS
- 0.42
- rvis_percentile_EVS
- 77.26
Haploinsufficiency Scores
- pHI
- 0.154
- hipred
- Y
- hipred_score
- 0.522
- ghis
- 0.437
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.775
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pde4c
- Phenotype
Gene ontology
- Biological process
- cAMP catabolic process;G protein-coupled receptor signaling pathway
- Cellular component
- extracellular space;cytosol;cilium
- Molecular function
- 3',5'-cyclic-AMP phosphodiesterase activity;protein binding;metal ion binding